Pharmafile.com’s weekly COVID-19 news round-up
November 25, 2020Research and Development
The coronavirus news this week sees more companies release their coronavirus vaccine results, with Pfizer and BioNTech backing up their …
The December 2020 issue of Pharmafocus is available to read free online now!
November 24, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, clinical trials, diabetes, outsourcing
The final 2020 monthly edition of Pharmafocus is available to read for free online now! After a long and theatrical …
FDA expands approval of Genentech’s Xofluza for post-exposure prevention of influenza
November 24, 2020Manufacturing and Production, Sales and Marketing FDA, Xofluza, influenza
Genentech has secured FDA approval for Xofluza (baloxavir marboxil) for the post-exposure prevention of influenza in patients at least 12 …
UK deaths currently a fifth higher than normal levels
November 24, 2020Manufacturing and Production
Deaths across the UK are a fifth higher than normal, according to new government data. Numbers released from UK Government …
Russia’s Sputnik COVID-19 vaccine has 91.4% efficacy after 28 days, new interim data show
November 24, 2020Manufacturing and Production, Research and Development COVID-19, Sputnik V, Vaccine
The National Research Center for Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF) have released a statement saying …
FDA approves Oxlumo for treating primary hyperoxaluria type 1
November 24, 2020Manufacturing and Production
The FDA has approved Oxlumo (lumasiran) as the first treatment for primary hyperoxaluria type 1 (PH1). This rare genetic condition …
Sanofi’s invasive meningococcal disease vaccine approved for EU use in four serotypes
November 23, 2020Research and Development, Sales and Marketing
Sanofi’s MenQuadfi combination vaccine has secured approval from the European Commission for the prevention of invasive meningococcal disease caused by …
Interim analysis for AstraZeneca’s COVID-19 vaccine finds 70% average efficacy
November 23, 2020Research and Development, Sales and Marketing AstraZeneca, COVID-19, Vaccine
Hot on the heels of Moderna and Pfizer/BioNTech who both have released very promising data for their mRNA COVID-19 vaccine …
Americans could get coronavirus vaccine by December, according to leader of Operation Warp Speed
November 23, 2020Sales and Marketing
Certain Americans could receive a coronavirus vaccine as early as next month, according to Dr Moncef Slaoui, Chief Scientific Adviser …
FDA grants Emergency Use Authorization for Regeneron’s antibody treatment
November 23, 2020Sales and Marketing
The FDA has granted Emergency Use Authorization for Regeneron’s coronavirus antibody treatment which was used to treat President Donald Trump …
Johnson & Johnson set to pay $120 million in New York baby powder case
November 23, 2020Sales and Marketing
A New York judge has ordered Johnson & Johnson to pay $120 million to a woman and her husband after …
World Health Organization does not recommend using remdesivir to treat COVID-19
November 20, 2020Medical Communications
The World Health Organization does not recommend using Gilead’s antiviral drug remdesivir to treat hospitalised COVID-19 patients, no matter how …
Eli Lilly and Ypsome partner to advance automated insulin delivery system
November 20, 2020Medical Communications
Eli Lilly has entered into a global non-exclusive agreement with Ypsomed for the advancement of an automated insulin delivery system …
Pfizer and BioNTech to request FDA Emergency Use Authorisation for their COVID-19 vaccine today
November 20, 2020Medical Communications, Sales and Marketing BioNTech, COVID-19, Pfizer, Vaccine
Pfizer and BioNTech are reportedly gearing up to submit a formal application for Emergency Use Authorisation to the FDA later …
First recombinant influenza vaccine approved in the European Union
November 20, 2020Medical Communications, Sales and Marketing Europe, influenza, pharma
The European Commission (EC) has just approved its first recombinant influenza vaccine for the European Union, awarding marketing authorisation to …
Top Ten most popular articles on Pharmafile.com this week
November 20, 2020Medical Communications
The top ten news stories this week centre around coronavirus vaccine clinical trial results, as Pfizer and BioNTech have backed …
Gilead’s lenacapavir meets primary goal in heavily treated and multidrug resistant HIV-1
November 19, 2020Research and Development Gilead, HIV, pharma
Gilead has pulled back the curtain on promising new data for its long-acting HIV-1 capsid inhibitor lenacapavir for heavily treated …
OPEN Health reveals new CEO appointment
November 19, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Open Health
Rob Barker has been named as the new Chief Executive Officer (CEO) at health communications and market access group OPEN …
First multiple sclerosis clinical trial for patients who can’t walk to begin recruitment
November 19, 2020Business Services
The first clinical trial to focus on multiple sclerosis (MS) patients who can’t walk will begin enrolling patients next year. …
Five Chinese coronavirus vaccines in overseas clinical trials
November 19, 2020Business Services
Five different coronavirus vaccines from China are being tested in Phase 3 trials around the world. The countries conducting the …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
